文献速递中医内科中药与中成药合理使用

中药药浴以卡泊三醇为对照治疗寻常型银屑病的系统评价与Meta分析

Chinese herbal medicine bath therapy for psoriasis vulgaris using topical calcipotriol as the comparator: A systematic review with meta-analysis and association rule analysis.
PubMed 文献 · J Ethnopharmacol · 2024-04-16

该系统评价纳入17项随机对照试验共1379例寻常型银屑病患者,比较中药药浴与局部卡泊三醇的疗效与安全性。结果显示中药药浴在降低PASI、PSSI和瘙痒VAS方面与卡泊三醇相当,且随访期复发率更低;联合卡泊三醇可额外改善PASI、PSSI、瘙痒VAS及IL-17、IL-23、CD3+和CD4+ T细胞。证据确定性为极低至中等。

要点

  • 中药药浴在改善PASI、PSSI和瘙痒VAS方面与卡泊三醇相当。
  • 中药药浴随访期复发率低于卡泊三醇,远期效果更持久。
  • 中药药浴联合卡泊三醇可额外改善皮损、瘙痒及免疫指标。

核心结论

  • 中药药浴疗效与局部卡泊三醇相当,但效果更持久。
  • 中药药浴联合卡泊三醇对成人寻常型银屑病有额外获益。
  • 证据确定性因纳入研究的方法学局限而降级。

研究设计与样本

  • 系统评价与Meta分析,检索9个数据库至2024年3月5日。
  • 纳入17项以卡泊三醇为对照的随机对照试验,共1379例参与者。
  • 采用RevMan 5.4、Stata 12.0和SPSS Clementine 12.0进行统计分析。
  • 使用GRADE方法评估结局证据确定性,并对中药进行关联规则分析。

主要发现

  • 治疗结束时,中药药浴在降低PASI、PSSI和瘙痒VAS方面与卡泊三醇效果相当。
  • 随访结束时,中药药浴复发率低于卡泊三醇,显示更优远期效果。
  • 治疗结束时,中药药浴联合卡泊三醇在PASI、PSSI、瘙痒VAS、IL-17、IL-23、CD3+和CD4+ T细胞方面显示额外获益。
  • 两组报告不良事件的参与者比例相似。
  • 关联规则分析识别出23个药对组合(包括桃仁与红花)及11味常用中药(如地肤子、白鲜皮、苦参)。

关键数值与推荐

  • 证据确定性根据GRADE评为极低、低或中等,原因包括偏倚风险、异质性和发表偏倚。
  • 关联规则分析识别出23个中药组合,包括桃仁与红花。
  • 关联规则分析识别出11味常用中药,如地肤子、白鲜皮和苦参。

临床怎么用

  • 中药药浴可作为寻常型银屑病的替代或辅助治疗,尤其适合需长期管理且关注复发者。
  • 中药药浴联合卡泊三醇可能增强疗效,可考虑用于成人寻常型银屑病。
  • 临床应用需结合GRADE证据确定性,关注纳入研究方法学局限对结论的影响。

局限性

  • 纳入研究存在偏倚风险关注或高风险。
  • 部分结局存在显著异质性和发表偏倚。
  • 证据确定性评为极低至中等,需双盲安慰剂对照试验进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ETHNOPHARMACOLOGICAL RELEVANCE: Psoriasis is a chronic inflammatory skin disease. Vitamin D analogues are the first-line topical agents for the long-term management of psoriasis. Chinese herbal medicine (CHM) bath therapy is commonly employed for psoriasis. However, the effects and safety of CHM bath therapy for psoriasis vulgaris, using topical calcipotriol as the comparator, remain inconclusive. Furthermore, the combination of herbs, a distinctive feature of CHM, is essential for its therapeutic effects due to the individual and synergistic properties of the herbs involved. AIM OF THE STUDY: The review was conducted to evaluate the effectiveness and safety of CHM bath therapy for psoriasis vulgaris, using calcipotriol as the comparator. Potential herbs and herb combinations of CHM bath therapy were also explored for further drug discovery. MATERIALS AND METHODS: Nine databases were searched from inception until March 05, 2024. Randomised controlled trials (RCTs) investigating CHM bath therapy, using calcipotriol as the comparator, were included. Statistical analyses were performed using RevMan 5.4, Stata 12.0 and SPSS Clementine 12.0 software. The evidence certainty for outcomes was assessed using the approach proposed by the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) Working Group. Moreover, association rule analysis on herbs identified in the systematic review was conducted to explore the potential herbs and herb combinations. RESULTS: A total of 17 RCTs involving 1,379 participants were included in this systematic review. The findings of this review revealed that: 1) CHM bath therapy produced comparable effects to calcipotriol in reducing Psoriasis Area and Severity Index (PASI), Psoriasis Scalp Severity Index (PSSI), and itch visual analogue scale (VAS) at the end of the treatment phase; as well as exhibited a superior long-term effect than calcipotriol through decreasing relapse rates at the end of the follow-up phase; 2) CHM bath therapy showed an additional benefit when combined with calcipotriol in managing psoriasis vulgaris at the end of the treatment phase, in terms of PASI, PSSI, itch VAS, IL-17, IL-23, CD3+ and CD4+ T cells. The certainty of the evidence was rated as 'very low', 'low' or 'moderate' based on the GRADE assessment, considering some concerns or high risk of bias of included studies, substantial heterogeneity, and existing publication bias of some outcomes. Additionally, the proportions of participants reporting adverse events were similar in both groups. Association rule analysis of all included herbs identified 23 herb combinations including Prunus persica (L.) Batsch and Carthamus tinctorius L., as well as 11 frequently used herbs, such as Kochia scoparia (L.) Schrad., Dictamnus dasycarpus Turcz. And Sophora flavescens Ait. CONCLUSIONS: The effects of CHM bath therapy were comparable with those of topical calcipotriol but demonstrated a longer-lasting effect. Combining CHM bath therapy with calcipotriol also provided an additional benefit for adult psoriasis vulgaris. However, the certainty of the evidence was downgraded due to the methodological limitations of included studies. To confirm the findings of this review, future investigations should involve double-blinded, placebo-controlled RCTs. Importantly, it appears worthwhile to consider further research for drug development utilising the identified herbs or herb combinations.

来源:J Ethnopharmacol,查看原文。版权归原作者所有。

引用

  1. Wang J, Zhang CS, Zhang AL, et al. Chinese herbal medicine bath therapy for psoriasis vulgaris using topical calcipotriol as the comparator: A systematic review with meta-analysis and association rule analysis. J Ethnopharmacol. 2024. PMID: 38621466. doi:10.1016/j.jep.2024.118166

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。